about
Therapeutic Benefits of Induced Pluripotent Stem Cells in Monocrotaline-Induced Pulmonary Arterial HypertensionTransglutaminase binding fusion protein linked to SLPI reduced corneal inflammation and neovascularization.Hepatic steatosis depresses alpha-1-antitrypsin levels in human and rat acute pancreatitis.Exploration of α1-antitrypsin treatment protocol for islet transplantation: dosing plan and route of administration.Identification of Potential Biomarkers for Rhegmatogenous Retinal Detachment Associated with Choroidal Detachment by Vitreous iTRAQ-Based Proteomic Profiling.Therapeutic compositions and uses of alpha1-antitrypsin: a patent review (2012 - 2015).Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.α-Linoleic acid enhances the capacity of α-1 antitrypsin to inhibit lipopolysaccharide-induced IL-1β in human blood neutrophilsC-Terminal Alpha-1 Antitrypsin Peptide: A New Sepsis Biomarker with Immunomodulatory Function.Ni(ii) ions cleave and inactivate human alpha-1 antitrypsin hydrolytically, implicating nickel exposure as a contributing factor in pathologies related to antitrypsin deficiency.LC-MS/MS quantitation of esophagus disease blood serum glycoproteins by enrichment with hydrazide chemistry and lectin affinity chromatography.Massive ascites and the heterozygous alpha 1 antitrypsin (α1 AT) living related donor liver in the homozygous child.Alpha-1 antitrypsin treatment of new-onset type 1 diabetes: An open-label, phase I clinical trial (RETAIN) to assess safety and pharmacokinetics.Fulminant hepatic failure in the setting of progressive ANCA-associated vasculitis associated with a rare alpha-1 antitrypsin phenotype, 'PiEE'.The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions.Alpha-1 Antitrypsin Inhibits ATP-Mediated Release of Interleukin-1β via CD36 and Nicotinic Acetylcholine Receptors.Alpha-1 Antitrypsin Attenuates M1 Microglia-Mediated Neuroinflammation in Retinal Degeneration.
P2860
Q28553086-0CE6A3A0-6CCD-44DA-AE95-F5F757A1FCB2Q35555197-24074654-E73A-4257-9F31-7D41A67A983CQ36346287-6028F944-7E68-4535-802E-F2EB3DD1F06AQ37427900-06D81F5F-D610-44AF-84AB-C3CDA9E41E21Q38439291-00BD2058-74F5-411E-87C0-062BFBF60736Q38769762-B78ECCB8-7AFF-4488-9066-42B7CB8AD6A7Q38937862-535DD5F8-3F69-4B8E-A32F-0C39B373A82AQ39565971-B4EB62F5-E953-4A8C-BAD5-A7D4A3D41F3DQ40624050-EDEE85D2-D4D8-49C9-A231-0AA8FEB3341FQ42702912-E8AE9D08-0333-4550-983A-3BBEA6540B58Q42998397-EA0E8B38-7CB1-4F82-AB37-F5898E0D5071Q47649677-2703E617-65DB-4FE2-AA25-728BFD14BACDQ53841619-0A734F4A-1F11-429D-93BB-469A0EE80A9FQ55103236-0A612DB7-439E-42F3-80D1-B7A1104109C8Q55259593-F9B1ACA4-1882-4F24-A4E3-41C1B06C9227Q55261353-BCA2AF3A-F297-4CEA-AE6E-584786E55068Q55360712-CFF65068-0BCC-477B-8089-9B7F7E47A8C0
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Immune-modulating effects of alpha-1 antitrypsin.
@en
type
label
Immune-modulating effects of alpha-1 antitrypsin.
@en
prefLabel
Immune-modulating effects of alpha-1 antitrypsin.
@en
P2860
P356
P1433
P1476
Immune-modulating effects of alpha-1 antitrypsin.
@en
P2093
Mario R Ehlers
P2860
P304
P356
10.1515/HSZ-2014-0161
P577
2014-10-01T00:00:00Z